期刊文献+

miR-16-5p通过调控PD-L1表达影响肝星状细胞炎症反应的研究

MiR-16-5p inhibits inflammatory response of hepatic stellate cells by regulating PD-L1 expression
下载PDF
导出
摘要 目的分析miR-16-5p在肝星状细胞中对程序性死亡受体-1(PD-1)表达的影响,并探讨其在肝纤维化及炎症反应中的作用机制。方法以大鼠肝星状细胞HSC-T6为研究对象,用5 ng/ml转化生长因子β1(TGF-β1)处理细胞0、24、48、72 h后,光镜下观察细胞形态,RT-qPCR法检测细胞TNF-α和IFN-γ表达水平,筛选出TGF-β1最佳作用时间。将细胞分为6组:对照组、模型组、miR-16-5p超表达组、miR-16-5p抑制组、超表达-空载组、抑制-空载组,采用RT-qPCR法检测miR-16-5p表达水平以验证转染效果;光镜下观察细胞形态变化;采用CCK-8试剂盒检测细胞增殖能力;采用Western blot法检测细胞PD-1配体(PD-L1)、NF-κB、p-NF-κB蛋白表达水平;采用RT-qPCR法检测细胞miR-16-5p、PD-L1以及炎症因子TNF-α、IFN-γ、IL-6和IL-10 mRNA表达水平。结果5 ng/ml TGF-β1处理细胞0、24、48、72 h后,细胞增殖且形态发生改变;炎症因子TNF-α、IFN-γ在TGF-β1处理48 h时后表达水平均明显增高(均P<0.05)。与模型组相比,对照组和miR-16-5p超表达组细胞miR-16-5p的mRNA表达水平以及PD-L1和IL-10蛋白表达水平均明显升高(均P<0.05),p-NF-κB/NF-κB的蛋白表达水平以及TNF-α、IFN-γ和IL-6的mRNA表达水平均降低(均P<0.05),miR-16-5p超表达组细胞增殖能力降低(P<0.05);miR-16-5p抑制组miR-16-5p、PD-L1、IL-10的mRNA表达水平均降低(均P<0.05),p-NF-κB/NF-κB的蛋白表达水平以及TNF-α、IFN-γ、IL-6的mRNA表达水平均升高(均P<0.05),细胞增殖能力增强(P<0.05)。结论miR-16-5p在肝星状细胞中通过调控PD-L1表达降低肝细胞炎症水平,抑制细胞增殖,其机制可能参与抑制肝纤维化发生。 Objective To investigate the effect of miR-16-5p on the inflammatory response of hepatic stellate cells and related mechanisms.Methods Rat hepatic stellate HSC-T6 cells were treated with 5 ng/ml TGB-β1 for 0,24,48 and 72 h.The morphology of HSC-T6 cells was observed with light microscope,and the expression of TNFαand IFNγwere detected by RT-qPCR to screen out the optimal action time of TGFβ1.HSC-T6 cells were divided into six groups:control group,model group,miR-16-5p mimics group,miR-16-5p inhibitor group,mimics NC group and inhibitor NC group.The expression of miR 16-5p was detected by RT-qPCR to verify the transfection effect.The morphological changes of cells were observed with light microscope;the proliferation activity of cells was detected by CCK 8 kit;the expression of PD-L1 and NFκB and p-NFκB were detected by Western blot.The mRNA expression levels of miR 16-5p,PD-L1,TNF-α,IFN-γ,IL-6 and IL-10 were detected by RT-qPCR.Results Cell proliferation and morphological changes were observed after treatment with 5 ng/ml TGFβ1 for 0,24,48 and 72 h,and the expression levels of TNFαand IFNγincreased significantly 48 h after treatment with TGFβ1(P<0.05).Compared with the model group,the mRNA expression levels of miR-16-5p and the protein expression levels of PD-L1 and IL-10 were significantly higher in the control and miR 16-5p mimic group cells(all P<0.05),and the protein expression levels of p-NFκB/NFκB and the mRNA expression levels of TNFα,IFNγand IL 6 were lower(all P<0.05),and the proliferation ability of cells in the miR 16-5p mimic group was reduced(P<0.05).The mRNA expression levels of miR 16-5p,PD-L1,and IL 10 were decreased in the miR 16-5p inhibitor group(all P<0.05),and the protein expression levels of p-NFκB/NF-κB and the mRNA expression levels of TNFα,IFNγ,and IL 6 were increased(all P<0.05),and the cell proliferation activity was increased(all P<0.05).Conclusion miR-16-5p can inhibit the inflammation response and proliferation of HSC cells by regulating the expression of PD-L1,which may be involved in the inhibition of liver fibrosis.
作者 詹东昂 柯峰 杨超 刘华 ZHAN Dong'ang;KE Feng;YANG Chao;LIU Hua(Department of Hospital Infection Management Office,Xiangyang Central Hospital(Affiliated Hospital of Hubei College of Arts and Sciences),Xiangyang 441021,China)
出处 《浙江医学》 CAS 2022年第19期2049-2055,共7页 Zhejiang Medical Journal
基金 湖北省卫生健康委员会科研项目(WJ2019F094)。
关键词 HSC-T6 肝星状细胞 miR-16-5p 程序性死亡受体-1 炎症因子 肝纤维化 HSC-T6 hepatic stellate cells miR-16-5p Programmed cell death-1 Inflammatory factors Liver fi-brosis
  • 相关文献

参考文献6

二级参考文献24

  • 1Bouchra Kitab,Hanane Salih Alj,Sayeh Ezzikouri,Soumaya Benjelloun.MicroRNAs as Important Players in Host-hepatitis B Virus Interactions[J].Journal of Clinical and Translational Hepatology,2015,3(2):149-161. 被引量:10
  • 2陈科全,周宇.核因子NF-κ_B与肝纤维化的关系研究现状[J].国际消化病杂志,2007,27(1):9-12. 被引量:10
  • 3Krawitt EL. Autoimrnune hepatitis[ J]. N Engl J Med, 2006, 354 (1): 54-66.
  • 4Nishimura H, Honjo T. PD - 1 : an inhibitory immuno - reeeptor involved in peripheral tolerance[J]. Trends Immunol, 2001, 22(5) : 265 - 268.
  • 5Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and manage- ment of autoimmune hepatitis [ J]. Hepatology, 2010, 51 (6) : 2193 -2213.
  • 6Sharpe AH, Wherry EJ, Ahmed R, et al. The function of pro- grammed cell death 1 and its ligands in regulating autoimmunity and infection[J]. Nat Immunol, 2007, 8(3) : 239 -245.
  • 7Grabie N, Gotsman I, Dacosta R, et al. Endothelial programmed death - 1 ligand 1 ( PD - L1 ) regulates CD8 + T cell mediated injury in the heart[J]. Circulation, 2007, 116(18) : 2062 -2071.
  • 8Menke J, Lucas JA, Zeller GC, et al. Programmed death 1 ligand ( PD - L1 ) and PD - I2 limit autoimmune kidney disease : distinct roles [ J]. J Immunol, 2007, 179 ( 11 ) : 7466 - 7477.
  • 9Koehn BH, Ford ML, Ferrer IR, et al. PD- 1 dependent mecha- nisms maintai peripheral tolerance of donor - reactive CD8 + T cells to transplanted tissue [ J ]. J Immunol, 2008, 181 ( 8 ) : 5313 - 5322.
  • 10Miyake Y, Yamamoto K, Matsushita H, et al. Muhieenter valida- tion study of anti - programmed cell death - 1 antibody as a serolog- ical marker for type 1 autoimmune hepatitis [ J ]. Hepatol Res, 214, 44(13) : 1299 -1337.

共引文献220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部